-
1 Comment
Hyphens Pharma International Limited is currently in a long term downtrend where the price is trading 5.6% below its 200 day moving average.
From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Hyphens Pharma International Limited's total revenue sank by 6.5% to $31M since the same quarter in the previous year.
Its net income has dropped by 37.8% to $1M since the same quarter in the previous year.
Finally, its free cash flow fell by 20.0% to $2M since the same quarter in the previous year.
Based on the above factors, Hyphens Pharma International Limited gets an overall score of 1/5.
| ISIN | None |
|---|---|
| Exchange | SG |
| CurrencyCode | SGD |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Market Cap | 90M |
|---|---|
| PE Ratio | 9.67 |
| Beta | 0.16 |
| Target Price | 0.35 |
| Dividend Yield | 5.2% |
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. It operates through Specialty pharma principals; Proprietary brands; and Medical hypermart and digital segments. The Specialty Pharma Principals segment markets and sells specialty pharmaceutical products, including contrast media products, Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products through distributorship or licensing, and supply agreements for the therapeutic areas, including dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, psychiatry, family medicine, and medical aesthetics. The Proprietary Brands segment develops, markets, and sells dermatological products, such as Cerdan, TDF, and CG 210 for the treatment of atopic dermatitis, acne, aging skin, and hyperpigmentation, as well as health supplement products under the Ocean Health brand name for heart, joint, physical, cognitive, eye, and children's health. The Medical Hypermart and Digital segment wholesales pharmaceuticals and medical supplies for healthcare professionals and institutions, and retail pharmacies through tele sales, direct sales, and online B2B platform. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1J5.SG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
